Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

• Main Authors: M. Tasso (Author), N. Bertolini (Author), E. Mostacciuolo (Author), S. Passavanti (Author), J.M.E. Luppino (Author), A. Del Puente (Author), R. Peluso (Author), F. Santelli (Author), R. Scarpa (Author), L. Costa (Author), F. Caso (Author)
• Format: Book
• Published: PAGEPress Publications, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The primary objectives of the study were to evaluate the efficacy and safety of tofacitinib and baricitinib up to 24 months of follow-up in patients with rheumatoid arthritis (RA) treated in Southern Italy. Patients' data, activity index, and clinimetric scores were collected at baseline (T0),...